K103742

Substantially Equivalent

ACCELL EVO3 (FORMERLY ACCELL A2I)

Applicant: Integra Life Sciences
Product code: MBP
Advisory panel: Orthopedic
Date received: 2010-12-23
Decision date: 2011-03-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.